This study has evidenced a significantly higher incorporation of the histone H3K9ac mark in three analyzed promoters of CYP19A1 in PCOS than in the control group, highlighting an epigenetic contribution to aromatase gene expression in PCOS patients during controlled ovarian stimulation. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.